{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001198251.1:c.158A>T",
          "cDNA Change": {
            "transcript": "NM_001198251.1",
            "ref": "A",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in a-syn gene"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease (familial form)",
    "MONDO": "MONDO:0005322"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Postmortem brain tissue",
        "Material Name": "Familial Parkinson's disease patient tissue",
        "Description": "Analysis of insoluble alpha-synuclein aggregates and nitrated alpha-synuclein in brain tissue."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001198251.1:c.158A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced aggregation",
          "Result Description": "Accumulation of insoluble alpha-synuclein and nitrated alpha-synuclein in multiple brain regions."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No specific threshold described; normal tissue morphology and protein distribution.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal accumulation of insoluble alpha-synuclein and nitrated alpha-synuclein in specific brain regions.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vitro fibrillization assay",
      "Material used": {
        "Material Source": "Recombinant alpha-synuclein",
        "Material Name": "Wild-type and A53T mutant alpha-synuclein",
        "Description": "Analysis of fibrillization kinetics and interaction with tau protein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001198251.1:c.158A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Accelerated aggregation",
          "Result Description": "A53T mutant alpha-synuclein exhibited significantly faster fibrillization kinetics and enhanced interaction with tau protein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal fibrillization kinetics and minimal tau interaction.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly accelerated fibrillization and enhanced tau interaction.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}